Literature DB >> 8384611

TNF receptor distribution in human tissues.

B Ryffel1, M J Mihatsch.   

Abstract

The nature and location of cells responding to tumor necrosis factor-alpha were investigated in situ by immunohistochemistry using monoclonal antibodies directed against the p75 and p55 proteins of the TNF receptor. Receptor expression was found in the thymus and secondary lymphoid tissues. In the thymus, the p75 receptor was confined to medullary lymphoblasts and dendritic cells, which costain with the Tac protein of the interleukin-2 receptor. In lymph nodes and other secondary lymphoid tissues, the p75 receptor was expressed on activated lymphocytes and interdigitating reticulum cells of the T cell areas, whereas the p55 receptor was confined to the germinal center dendritic reticulum cells, which are the main site of TNF-alpha production. TNF receptor proteins were up-regulated in reactive hyperplasia together with increased TNF-alpha expression. Surprisingly, no TNF-R was detectable on nonlymphoid tissues. The species specificity of these TNF-antibodies was high: whereas the antibodies cross-reacted with epitopes in nonhuman primates, no immunoreactivity was detected in lower animal species, e.g., dog, rabbit, and rodents. The data presented suggest that TNF-alpha, which is produced by germinal center DRCs, might regulate an in vivo immune response through autocrine and paracrine pathways, e.g., through the p55 and p75 receptor proteins, which are expressed at different sites on the lymphoid tissue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384611     DOI: 10.1016/b978-0-12-364935-5.50015-8

Source DB:  PubMed          Journal:  Int Rev Exp Pathol        ISSN: 0074-7718


  8 in total

Review 1.  Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis.

Authors:  R W Ledeen; G Chakraborty
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

2.  Tumor necrosis factor-alpha binding in porcine primary stromal-vascular cell cultures.

Authors:  Y D Tchoukalova; D B Hausman; K Angelova; G J Hausman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-05       Impact factor: 2.416

3.  Immunological markers of childhood fevers in an area of intense and perennial malaria transmission.

Authors:  N Hurt; M Thein; T Smith; G Bordmann; H Gallati; N Drees; M Tanner; N Weiss
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

4.  Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75.

Authors:  K C Sheehan; J K Pinckard; C D Arthur; L P Dehner; D V Goeddel; R D Schreiber
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

5.  Development, maturation and subsequent activation of follicular dendritic cells (FDC): immunohistochemical observation of human fetal and adult lymph nodes.

Authors:  Naoko Kasajima-Akatsuka; Kunihiko Maeda
Journal:  Histochem Cell Biol       Date:  2006-02-10       Impact factor: 4.304

6.  Chimeric form of tumor necrosis factor-alpha has enhanced surface expression and antitumor activity.

Authors:  R Rieger; D Whitacre; M J Cantwell; C Prussak; T J Kipps
Journal:  Cancer Gene Ther       Date:  2008-07-25       Impact factor: 5.987

7.  Distinct roles of lymphotoxin alpha and the type I tumor necrosis factor (TNF) receptor in the establishment of follicular dendritic cells from non-bone marrow-derived cells.

Authors:  M Matsumoto; Y X Fu; H Molina; G Huang; J Kim; D A Thomas; M H Nahm; D D Chaplin
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

8.  Relationship between Dynamics of TNF-α and Its Soluble Receptors in Saliva and Periodontal Health State.

Authors:  Ryota Kibune; Kosuke Muraoka; Masaki Morishita; Wataru Ariyoshi; Shuji Awano
Journal:  Dent J (Basel)       Date:  2022-02-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.